Tags

Type your tag names separated by a space and hit enter

Challenges in natural health product research: The importance of standardization.
Proc West Pharmacol Soc. 2007; 50:24-30.PW

Abstract

Before there can be acceptance of natural health products (NHPs) or "phytomedicines" by the Western medical community, questions related to active ingredients, mechanisms of action, toxicology, and drug interactions will need to be satisfactorily addressed. Since NHPs are generally manufactured from highly variable raw materials, identifying the therapeutically active ingredients can be challenging. Standardization according to all known bioactive components is critical to ensure consistent pharmacological and clinical results. CV Technologies, Inc. has made great strides in resolving these challenges through the patented technology, ChemBioPrint. During early ChemBioPrint product development, the optimal active components of a natural extract are identified and characterized chemically (chemical fingerprinting) and pharmacologically through a variety of activity assays (biological fingerprinting). Subsequent manufacturing steps ensure each batch is standardized accordingly and has consistent composition and efficacy. Case studies will be presented on two commercially available ChemBioPrint products: COLD-fX (an immune-modulator) and REMEMBER-fX (a neuro-modulator). Unique and important structure-function relationships exist between the major classes of bioactive molecules from the shared source material of these two products, Panax quinquefolius. Through numerous published and ongoing clinical trials and pharmacological studies, these ChemBioPrint products have been shown to be consistent, safe and effective. The future directions of NHP research will be discussed, including the requirements for accurate reporting of study results related to ingredient and standardization descriptions.

Authors+Show Affiliations

CV Technologies Inc., Edmonton Research Park, Edmonton, Alberta, Canada. drshan@cvtechnologies.comNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18605225

Citation

Shan, Jacqueline J., et al. "Challenges in Natural Health Product Research: the Importance of Standardization." Proceedings of the Western Pharmacology Society, vol. 50, 2007, pp. 24-30.
Shan JJ, Rodgers K, Lai CT, et al. Challenges in natural health product research: The importance of standardization. Proc West Pharmacol Soc. 2007;50:24-30.
Shan, J. J., Rodgers, K., Lai, C. T., & Sutherland, S. K. (2007). Challenges in natural health product research: The importance of standardization. Proceedings of the Western Pharmacology Society, 50, 24-30.
Shan JJ, et al. Challenges in Natural Health Product Research: the Importance of Standardization. Proc West Pharmacol Soc. 2007;50:24-30. PubMed PMID: 18605225.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Challenges in natural health product research: The importance of standardization. AU - Shan,Jacqueline J, AU - Rodgers,Kathryn, AU - Lai,Chien-Tsai, AU - Sutherland,Sharla K, PY - 2008/7/9/pubmed PY - 2008/8/1/medline PY - 2008/7/9/entrez SP - 24 EP - 30 JF - Proceedings of the Western Pharmacology Society JO - Proc. West. Pharmacol. Soc. VL - 50 N2 - Before there can be acceptance of natural health products (NHPs) or "phytomedicines" by the Western medical community, questions related to active ingredients, mechanisms of action, toxicology, and drug interactions will need to be satisfactorily addressed. Since NHPs are generally manufactured from highly variable raw materials, identifying the therapeutically active ingredients can be challenging. Standardization according to all known bioactive components is critical to ensure consistent pharmacological and clinical results. CV Technologies, Inc. has made great strides in resolving these challenges through the patented technology, ChemBioPrint. During early ChemBioPrint product development, the optimal active components of a natural extract are identified and characterized chemically (chemical fingerprinting) and pharmacologically through a variety of activity assays (biological fingerprinting). Subsequent manufacturing steps ensure each batch is standardized accordingly and has consistent composition and efficacy. Case studies will be presented on two commercially available ChemBioPrint products: COLD-fX (an immune-modulator) and REMEMBER-fX (a neuro-modulator). Unique and important structure-function relationships exist between the major classes of bioactive molecules from the shared source material of these two products, Panax quinquefolius. Through numerous published and ongoing clinical trials and pharmacological studies, these ChemBioPrint products have been shown to be consistent, safe and effective. The future directions of NHP research will be discussed, including the requirements for accurate reporting of study results related to ingredient and standardization descriptions. SN - 0083-8969 UR - https://www.unboundmedicine.com/medline/citation/18605225/Challenges_in_natural_health_product_research:_The_importance_of_standardization_ DB - PRIME DP - Unbound Medicine ER -